#10. Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model
Thangaraj JL, Jung SH, Vo MC, Chu TH, Phan MT, Lee KH, Ahn SY, Kim M, Song GY, Ahn JS, Yang DH, Kim HJ, Cho D*, Lee JJ*
2023 · Cancer Immunol Immunother
PMID: 36385211